Toth Financial Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

Toth Financial Advisory’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$157K	Hold	300	–	–	0.02%	251
2026 Q2	$149K	Sell	300 -6	-2%	-$2.66K	0.01%	258
2026 Q1	$137K	Buy	306 +76	+33%	+$35.4K	0.02%	249
2025 Q4	$104K	Hold	230	–	–	0.01%	260
2025 Q3	$90.1K	Hold	230	–	–	0.01%	278
2025 Q2	$102K	Hold	230	–	–	0.01%	242
2025 Q1	$112K	Hold	230	–	–	0.01%	234
2024 Q4	$92.6K	Sell	230 -1,320	-85%	-$612K	0.01%	246
2024 Q3	$721K	Buy	1,550 +1,450	+1,450%	+$697K	0.09%	145
2024 Q2	$46.9K	Hold	100	–	–	0.01%	301
2024 Q1	$41.8K	Hold	100	–	–	0.01%	309
2023 Q4	$40.7K	Hold	100	–	–	0.01%	315
2023 Q3	$34.8K	Hold	100	–	–	0.01%	305
2023 Q2	$35.2K	Sell	100 -39	-28%	-$13.1K	0.01%	312
2023 Q1	$43.8K	Buy	139 +39	+39%	+$11.7K	0.01%	289
2022 Q4	$28.9K	Hold	100	–	–	﹤0.01%	340
2022 Q3	$29K	Hold	100	–	–	0.01%	340
2022 Q2	$28K	Hold	100	–	–	﹤0.01%	334
2022 Q1	$26K	Hold	100	–	–	﹤0.01%	357
2021 Q4	$22K	Buy	100 +82	+456%	+$15.9K	﹤0.01%	395
2021 Q3	$3K	Hold	18	–	–	﹤0.01%	623
2021 Q2	$4K	Hold	18	–	–	﹤0.01%	529
2021 Q1	$4K	Hold	18	–	–	﹤0.01%	537
2020 Q4	$4K	Sell	18 -2,875	-99%	-$660K	﹤0.01%	482
2020 Q3	$787K	Sell	2,893 -1,610	-36%	-$444K	0.15%	110
2020 Q2	$1.31M	Buy	4,503 +443	+11%	+$120K	0.28%	83
2020 Q1	$966K	Buy	4,060 +1,330	+49%	+$305K	0.28%	78
2019 Q4	$598K	Buy	+2,730	New	+$553K	0.12%	113
2019 Q2	–	Sell	-1,642	Closed	-$302K	–	478
2019 Q1	$302K	Buy	+1,642	New	+$303K	0.07%	138

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Toth Financial Advisory's VRTX Position: Q3 2026 in Review

Toth Financial Advisory held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 300 shares worth $157K. The position accounts for 0.02% of the portfolio, ranked #251.

Toth Financial Advisory first reported a position in VRTX in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.31M in Q2 2020. 440 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Toth Financial Advisory held 300 shares of Vertex Pharmaceuticals worth $157K as of Q3 2026.
Toth Financial Advisory left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
Vertex Pharmaceuticals made up 0.02% of Toth Financial Advisory's portfolio in Q3 2026, its #251 holding.
Toth Financial Advisory first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 29 quarters since.
Toth Financial Advisory's Vertex Pharmaceuticals position peaked at $1.31M in Q2 2020.
440 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.